Download PDF
Thromb Haemost 1984; 51(02): 283-290
DOI: 10.1055/s-0038-1661078
International Committee Communications
Schattauer GmbH Stuttgart

Registry of Prospective Clinical Trials - Sixth Report[*]

M Verstraete
The Center for Thrombosis and Vascular Research, Department of Medical Research, University of Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 11 November 1983

Accepted 21 February 1984

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints

* Space limitation does not allow to publish the full detailed Sixth Report of the Registry of Prospective Clinical Trials, which however can be obtained from the ICTH-office, do H. R. Roberts, Department of Pathology and Medicine, Preclinical Building 228-H, University of South Carolina, Chapel Hill, N. C. 27514, USA


 

  • References

  • 1 Verstraete M. Registry of prospective clinical trials. First report. Thrombos Diathes Haemorrh 1975; 33: 655-663
    PubMedGoogle Scholar
  • 2 Verstraete M. Registry of prospective clinical trials. Second report. Thromb Haemostas 1976; 36: 239-250
    PubMedGoogle Scholar
  • 3 Verstraete M. Registry of prospective clinical trials. Third report. Thromb Haemostas 1978; 39: 759-767
    PubMedGoogle Scholar
  • 4 Verstraete M. Registry of prospective clinical trials. Fourth report. Thromb Haemostas 1980; 43: 176-181
    PubMedGoogle Scholar
  • 5 Verstraete M. Registry of prospective clinical trials. Fifth report. Thromb Haemostas 1982; 48: 334-338
    PubMedGoogle Scholar
  • 6 The Sixty Plus Reinfarction Study Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1980 2. 889-894
    PubMedGoogle Scholar
  • 7 The Sixty Plus Reinfarction Study Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1982 1. 64-67
    PubMedGoogle Scholar
  • 8 Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-317
    CrossrefPubMedGoogle Scholar
  • 9 Schröder R, Biamino G, von Leitner ER, Linderer T, Brüggemann T, Heitz J, Vöhringer HF, Wegscheider K. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983; 67: 536-548
    CrossrefPubMedGoogle Scholar
  • 10 Kennedy JW, Fritz JK, Ritchie JL. Streptokinase in acute myocardial infarction: Western Washington randomized trial - Protocol and progress report. Am Heart J 1982; 104: 899-911
    CrossrefPubMedGoogle Scholar
  • 11 Carter AB. Anticoagulant treatment in progressing stroke. Br Med J 1961; 2: 70-73
    CrossrefPubMedGoogle Scholar
  • 12 Fisher CM. The use of anticoagulants in cerebral thrombosis. Neurology 1958; 8: 311-332
    CrossrefPubMedGoogle Scholar
  • 13 Fisher CM. Anticoagulant therapy in cerebral thrombosis and cerebral embolism. Neurology 1961; 11: 119-131
    CrossrefPubMedGoogle Scholar
  • 14 Millikan CH. Anticoagulant therapy in cerebrovascular disease. In Fourth Princeton Conference on CVD. Millikan CH, Siekert RG, Whisnant JP. (eds) p 183 Grune and Stratton; New York: 1965
    Google Scholar
  • 15 Morris JW, Lassen NA. Important points in treatment of progressive stroke. Stroke 1982; 13: 403-404
    CrossrefPubMedGoogle Scholar
  • 16 Joint Committee for Stroke Resources. XVI. Cerebral ischemia: The role of thrombosis and of antithrombotic therapy. Stroke. 1977 8. 147-176
    PubMedGoogle Scholar
  • 17 Lodder J, van der Lugt PJ M. Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 1983; 14: 42-46
    CrossrefPubMedGoogle Scholar
  • 18 Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983; 14: 5-14
    CrossrefPubMedGoogle Scholar
  • 19 Verstraete M, Vermylen J, Verhaeghe RH. Peripheral arterial diseases. Clin Hematol 1981; 10: 669-696
    PubMedGoogle Scholar
  • 20 Verhaeghe R, Verstraete M, Schetz J, Vanhove Ph, Suy R, Vermylen J. Clinical trial of brinase and anticoagulants as a method of treatment for advanced limb ischemia. Eur J Clin Pharmacol 1979; 16: 165-170
    CrossrefPubMedGoogle Scholar
  • 21 Gruber UF, Saldeen T, Brokop T, Eklöf B, Eriksson I, Goldie I, Gran L, Hohl M, Jonsson T, Kristersson S, Ljungstrom KG, Lund T, Maartman Moe H, Svensjö E, Thomson D, Torhorst J, Trippestad A, Ulstein M. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Br Med J 1980; 1: 69-72
    PubMedGoogle Scholar
  • 22 van de Loo JC V, Kriessmann A, Trübestein G, Knoch K, De Swart CA M, Asbeck F, Marbet GA, Schmitt HE, Sewell AF, Duckert F, Theiss W, Ritz R. Controlled multicenter pilot study of urokinase - heparin and streptokinase in deep vein thrombosis. Thromb Haemostas 1983; 50: 660-663
    PubMedGoogle Scholar
  • 23 EPSIM Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med. 1982 307. 701-708
    PubMedGoogle Scholar
  • 24 Anturan Reinfarction Italian Study Group. Sulphinpyrazone in postmyocardial infarction. Lancet. 1982 1. 237-242
    PubMedGoogle Scholar
  • 25 Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study Stroke 1983; 14: 15-22
    CrossrefPubMedGoogle Scholar
  • 26 Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study N Engl J Med 1983; 309: 396-403
    CrossrefPubMedGoogle Scholar
  • 27 Chesebro JH, Fuster V, Elveback LR, Me GoonD, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541
    CrossrefPubMedGoogle Scholar